Medicare’s $50 GLP-1 Weight Loss Bridge | Dayton News

Dayton News Today | 2 Min News | The Daily News Now! · Jul 18, 2026 · 2m

Medicare’s launching a bold new move: starting July 2026, millions of older Americans with obesity or related conditions can get pricey GLP-1 weight-loss drugs for just $50 a month under the Medicare GLP-1 Bridge trial. Eligibility is tight—targeting those with high BMI or serious health issues like heart failure or prediabetes—but it’s a game-changer for access. Covered drugs include Wegovy, Zepbound, and Mounjaro. Your doctor must prescribe and authorize it. Not everyone qualifies, and this isn’t a full rollout—but it’s a major step toward making these life-changing meds affordable for…